VolitionRx Ltd
VNRX
15 hedge funds and large institutions have $9.66M invested in VolitionRx Ltd in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 1 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
0% more funds holding
Funds holding: 15 → 15 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.02% less ownership
Funds ownership: 0.68% → 0.66% (-0.02%)
9% less capital invested
Capital invested by funds: $10.6M → $9.66M (-$928K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$73.8K |
| 2 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$41.4K |
| 3 |
LIM
Lagoda Investment Management
New York
|
+$30.8K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.59K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$621 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$55K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$14.5K |
| 3 |
Goldman Sachs
New York
|
-$6.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LIM
1
Lagoda Investment Management
New York
| $5.11M | +$30.8K | +447 | +0.6% |
|
|
SCA
2
Southpoint Capital Advisors
New York
| $2.52M | – | – | – |
|
|
KCM
3
Knoll Capital Management
Miami,
Florida
| $1.45M | – | – | – |
|
4
Geode Capital Management
Boston,
Massachusetts
| $200K | – | – | – |
|
|
5
Morgan Stanley
New York
| $163K | +$73.8K | +1,070 | +70% |
|
|
6
Goldman Sachs
New York
| $61K | -$6.9K | -100 | -9% |
|
|
GBA
7
Garrison Bradford & Associates
New York
| $49K | – | – | – |
|
|
BRWA
8
B. Riley Wealth Advisors
Boca Raton,
Florida
| $38K | +$41.4K | +600 | New |
|
9
Bank of New York Mellon
New York
| $32K | +$276 | +4 | +0.8% |
|
|
10
UBS Group
Zurich,
Switzerland
| $11K | -$14.5K | -210 | -54% |
|
11
Creative Planning
Overland Park,
Kansas
| $10K | – | – | – |
|
|
BFA
12
BlackRock Fund Advisors
San Francisco,
California
| $7K | +$621 | +9 | +8% |
|
|
BA
13
BlackRock Advisors
Wilmington,
Delaware
| $4K | – | – | – |
|
14
BlackRock
New York
| $3K | – | – | – |
|
|
TRCT
15
Tower Research Capital (TRC)
New York
| $2K | +$1.59K | +23 | +230% |
|
|
VKH
16
Virtu KCG Holdings
New York
| – | -$55K | -772 | Closed |
|
VNRX Hedge Fund Activity: Q2 2016 in Review
15 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q2 2016, worth a combined $9.66M — down 8.8% from $10.6M a quarter earlier.
Fund positioning in VNRX was balanced in Q2 2016: 1 fund opened new positions, 1 closed out, 5 added to existing stakes and 2 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $73.8K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $55K sold.
- 15 institutional investors held VolitionRx Ltd (VNRX) as of Q2 2016, unchanged from Q1 2016.
- Funds reported $9.66M of VolitionRx Ltd stock for Q2 2016, down 8.8% quarter-over-quarter.
- 1 fund opened new VolitionRx Ltd positions in Q2 2016 and 1 closed out, a net change of 0 holders.
- The largest VolitionRx Ltd buyer in Q2 2016 was Morgan Stanley, an estimated $73.8K added.
- The largest VolitionRx Ltd seller in Q2 2016 was Virtu KCG Holdings, an estimated $55K sold.
Based on aggregated 13F filings for Q2 2016.